Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
N BRERETON MEDICAL TECHNOLOGIES via THE CONSILIO GROUP
2026 · first_quarter · 1T
FenBlock is a patented, non-invasive medical device designed to help patients safely taper off prescribed fentanyl patches by gradually reducing the amount of medication absorbed through the skin.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NATERA, INC. via THE CONSILIO GROUP
2026 · first_quarter · 1T
Source: Senate LDA
Expanded Genetic Screening Act.
Expanded Genetic Screening Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIGAKU RAMAN TECHNOLOGIES, INC. via THE CONSILIO GROUP
2026 · first_quarter · 1T
Integrating Rigakus handheld Raman devices.
Integrating Rigakus handheld Raman devices.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), U.S. Customs & Border Protection
N BRERETON MEDICAL TECHNOLOGIES via THE CONSILIO GROUP
2025 · fourth_quarter · Q4
FenBlock is a patented, non-invasive medical device designed to help patients safely taper off prescribed fentanyl patches by gradually reducing the amount of medication absorbed through the skin.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NATERA, INC. via THE CONSILIO GROUP
2025 · fourth_quarter · Q4
Expanded Genetic Screening Act.
Expanded Genetic Screening Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIGAKU RAMAN TECHNOLOGIES, INC. via THE CONSILIO GROUP
2025 · fourth_quarter · Q4
Integrating Rigakus handheld Raman devices.
Integrating Rigakus handheld Raman devices.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), U.S. Customs & Border Protection
N BRERETON MEDICAL TECHNOLOGIES via THE CONSILIO GROUP
2025 · third_quarter · Q3
FenBlock is a patented, non-invasive medical device designed to help patients safely taper off prescribed fentanyl patches by gradually reducing the amount of medication absorbed through the skin.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NATERA, INC. via THE CONSILIO GROUP
2025 · third_quarter · Q3
Expanded Genetic Screening Act.
Expanded Genetic Screening Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIGAKU RAMAN TECHNOLOGIES, INC. via THE CONSILIO GROUP
2025 · third_quarter · 3A
Integrating Rigakus handheld Raman devices.
Integrating Rigakus handheld Raman devices.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), U.S. Customs & Border Protection
RIGAKU RAMAN TECHNOLOGIES, INC. via THE CONSILIO GROUP
2025 · third_quarter · Q3
Integrating Rigakus handheld Raman devices.
Integrating Rigakus handheld Raman devices.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), U.S. Customs & Border Protection
N BRERETON MEDICAL TECHNOLOGIES via THE CONSILIO GROUP
2025 · second_quarter · Q2
FenBlock is a patented, non-invasive medical device designed to help patients safely taper off prescribed fentanyl patches by gradually reducing the amount of medication absorbed through the skin.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
N BRERETON MEDICAL TECHNOLOGIES via THE CONSILIO GROUP
2025 · second_quarter · RR
FenBlock️, a novel solution to the opioid crisis through a data-driven, titration-based methodology. FenBlock uses a graduated dose barrier to manage substance dependency with precision, providing a controlled and effective path to recovery.
NATERA, INC. via THE CONSILIO GROUP
2025 · second_quarter · Q2
Expanded Genetic Screening Act.
Expanded Genetic Screening Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIGAKU RAMAN TECHNOLOGIES, INC. via THE CONSILIO GROUP
2025 · second_quarter · Q2
Integrating Rigakus handheld Raman devices.
Integrating Rigakus handheld Raman devices.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), U.S. Customs & Border Protection
NATERA, INC. via THE CONSILIO GROUP
2025 · first_quarter · Q1
Expanded Genetic Screening Act.
Expanded Genetic Screening Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIGAKU RAMAN TECHNOLOGIES, INC. via THE CONSILIO GROUP
2025 · first_quarter · Q1
Integrating Rigakus handheld Raman devices.
Integrating Rigakus handheld Raman devices.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), U.S. Customs & Border Protection